Ascletis Announces Promising Results for ASC50, a New Psoriasis Treatment, in U.S. Clinical Study #USA #Hong_Kong #Ascletis_Pharma #ASC50 #Psoriasis_Treatment
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialAscletis Pharma Celebrates Inclusion on Hong Kong Stock Connect Listing #China #Hong_Kong #Ascletis_Pharma #Hong_Kong_Stock_Connect #Biotechnology_Company